Highly expressed in epithelial cancer! It is used as a diagnostic and prognostic marker for cancers derived from epithelial cells.
"EpCAM (CD326)" is a membrane-bound glycoprotein involved in cell adhesion, cell proliferation, and tumor progression. It has been found that the number of circulating tumor cells (CTCs) derived from solid tumors in the blood correlates with the prognosis of patients with metastatic breast cancer, prostate cancer, and colorectal cancer. Since EpCAM is expressed in CTCs, it is utilized in measurements of CTCs in the blood. 【Product Lineup】 ■ Anti-Human EpCAM Monoclonal Antibody KIJY1N ■ Anti-Human EpCAM Monoclonal Antibody KIJY2 ■ Anti-Human EpCAM Monoclonal Antibody KIJY3N *For more details, please download the PDF or feel free to contact us.
Inquire About This Product
basic information
**Features** EpCAM, a membrane-spanning glycoprotein, consists of three parts: the N-terminal EDF domain as the extracellular portion, a TY-like domain, and an unidentified cysteine region adjacent to a single membrane-spanning helix. Our anti-EpCAM is an antibody against the CP region developed by researchers at the Institute of Aging Medicine, Eastern University. *For more details, please download the PDF or feel free to contact us.*
Price range
Delivery Time
Applications/Examples of results
For more details, please download the PDF or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Our company utilizes technology for the production of diagnostic antibodies to manufacture antibodies widely applied in various fields. Additionally, we leverage our extensive technology and experience accumulated over many years in immunology and cell culture to undertake contract work tailored to our customers' needs. Please feel free to contact us if you have any inquiries.